Showing results (141-150 of 197) with videos related to
Sort By:
Pageof 20
Chest|November 24, 2005
Comparison of lung volume reduction surgery and physical training on health status and physiologic outcomes: a randomized controlled clinical trialGunnar Hillerdal, Claes-Göran Löfdahl, Kerstin Ström, et al.ERJ Open Research|February 18, 2026
Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysisKathleen Zwijsen, Reinier R L Wener, Ellen Heirwegh, et al.Chest|July 9, 2011
The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factorKevin Hollevoet, Kristiaan Nackaerts, Olivier Thas, et al.Clinical Lung Cancer|January 13, 2019
Prognostic Understanding and Quality of Life in Patients With Advanced Lung Cancer: A Multicenter StudyAnnelies Janssens, Sofia Derijcke, Daniëlle Galdermans, et al.Lung Cancer (Amsterdam, Netherlands)|June 3, 2008
EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopyKurt G Tournoy, Robert C Rintoul, Jan P van Meerbeeck, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinomaMark G Kris, Giuseppe Giaccone, Angela Davies, et al.European Journal of Radiology|December 26, 2001
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseasesMuzaffer Metintas, Irfan Ucgun, Osman Elbek, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 16, 2011
Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesotheliomaKevin Hollevoet, Kristiaan Nackaerts, Robert Gosselin, et al.The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.American Journal of Respiratory Cell and Molecular Biology|February 21, 2004
Proteomic analysis of exosomes isolated from human malignant pleural effusionsMartin P Bard, Joost P Hegmans, Annabrita Hemmes, et al.Pageof 20